Abstract We have incorporated bisphosphonates and antibiotics simultaneously into a biomimetic hydroxyapatite implant coating aiming to use the interaction between drug-molecules and hydroxyapatite to enable local release of the two different substances to obtain a dual biological effect. A sustained release over for 43 h of antibiotics (cephalothin) was achieved without negative interference from the presence of the bisphosphonate (clodronate) which, in turn, successfully bonded to the coating surface. To our knowledge, this is the first study that indicates the possibility to simultaneously incorporate both antibiotics and bisphosphonates to an implant coating, a strategy that is believed to improve implant stability and reduce implant-related infections.
Introduction
Post-surgical infections and insufficient bone growth around prosthetic implants are two concerns within orthopedics that need to be addressed to improve the clinical outcome for the increasing number of patients receiving implants annually. Revision surgery due to infection and/or implant failure imposes considerable strain on both afflicted patients and the health care system, where the procedure in most cases is substantially more complicated and costly compared with the index surgery (Lavernia et al. 1995) . In the U.S., almost 40% of all nosocomial infections are due to surgical site infections (Mangram et al. 1999 ) and the incident rate can be as high as 10% for some procedures (spinal surgery) (Carreon et al. 2003) . In a recent retrospective study, of 9,245 patients undergoing primary hip or knee arthroplasty 65% of the developed infections appeared within the first year (Pulido et al. 2008) , indicating that perioperative infections associated with the open procedure accounts for the majority of infections.
The interface between prosthetic implant and tissue is a region of local immune depression with reduced resistance to microbes, often referred to as an immuneincompetent fibro-inflammatory zone (Gristina 1994) . Also, implant migration due instability in the interface between bone and implant can damage the tissues and almost completely deplete the immune defenses (Campoccia et al. 2006) . Thus, these peri-prosthetic regions are highly sensitive for bacteria colonization and biofilm formation. By using an implant coating as carrier for antibiotics, a bactericidal effect can be obtained directly where it is needed, namely in the direct vicinity of the implant (Schmidmaier et al. 2006) . This is believed to reduce the number of early infections associated with bacteria entering the incision wound as it prevents immediate bacteria adhesion on the implant following surgery (Stigter et al. 2004) . By letting the implant surface deliver bisphosphonates as well, a more dense bone formation is expected around the implant, which will increase the implant stability (McLeod et al. 2006; Gao et al. 2009 ). This dual effect is proposed to reduce the infection rate and at the same time increase the implant stability.
Biomimetic hydroxyapatite (BHA) is a suitable interface between bone and implant due to its close resemblance with the apatite mineral in bone (Barrere et al. 2003) . BHA-coatings can carry antibiotics (Stigter et al. 2004; Brohede et al. 2009a ) and bisphosphonates (Å berg et al. 2009 ) individually but, to our knowledge, have these substances never been loaded simultaneously to a BHA-coating, which would promote a beneficial dual effect as described above. Thus, the present study was carried out to investigate the possibility to perform such a coloading.
Materials and methods

Drugs
The drugs used in the present study were the antibiotic Cephalothin (Sigma, art. nr: C3050) and the bisphosphonate, clodronate (Sigma).
Coating deposition and drug loading Circular substrates of titanium grade 2 (diameter = 14 mm) were coated with biomimetic hydroxyapatite (BHA) as described earlier (Brohede et al. 2009b ). Briefly, a thin coating comprised mainly of crystalline anatase TiO 2 was deposited on the substrates by physical vapor deposition. Subsequently, each of the coated substrates were immersed in 40 ml Dulbecco's phosphate buffered saline with for 7 days at 60°C for precipitation of a BHA layer on the surface. Thereafter, the coated samples where subjected to a loading procedure where they were placed in individual plastic tubes containing 40 ml PBS and either 1 mg cephalothin, 1 mg clodronate or 1 mg of both, see Table 1 . The samples were left in the tubes for 1 day at 40°C before taken out and gently rinsed in distilled water.
Analysis
Clodronate contains two Cl that are bonded to C which makes it possible to detect clodronate at the surfaces of the BHA coating by analyzing the presence of Cl. This was done with X-ray photoelectron spectroscopy (XPS, Quantum 2000, Physical Instruments). The atomic concentration of Cl in both co-loaded and single loaded samples was measured and compared to the presence in reference BHA samples. The analyses were performed on quadratic areas of the BHA coatings with the dimensions 200 lm 9 200 lm. The surface charges were neutralized with argon ions during the analysis.
The release of cephalothin was analyzed at 238 nm. Four plates were placed in 10 ml deionized water that was circulated through the measuring cell using a peristaltic pump and the absorption was measured regularly until a plateau was reached.
Results and discussion
The elemental composition on the different surfaces is given in Table 2 . The amount of Cl was higher for the samples immersed in the clodronate-containing liquids, indicating an incorporation of clodronate into those surfaces. The Cl content of the other sample surfaces is due to incorporation of Cl from the PBS during the precipitation of BHA. The Cl 2p peak for the different surfaces is shown in Fig. 1 , from which it is clear that the binding energy is slightly higher for the Cl in the clodronate containing samples. This indicates a difference in binding state of the Cl due to a different atomic environment and supports the statement that clodronate is incorporated in the surfaces. The amount of Cl is low but shorter loading times promote more efficient loading with an optimum at 1 h of soaking (McLeod et al. 2006 ). Yet, since Cl only constitutes 13.3% of the clodronate molecule, the concentration of Cl at the surface is not a direct measure of the amount of incorporated clodronate, which in reality, is higher. The incorporation of clodronate was unaffected or even improved by the presence of cephalothin in the PBS during loading.
A continuous diffusion controlled release of cephalothin for 43 h was achieved for both the coloaded samples and the samples loaded with cephalothin alone, see Fig. 1 . The release rate was found to be somewhat faster for the co-loaded samples during the first 5 h of release and almost identical during the remaining release period.
The release rate of cephalothin was faster from the co-loaded samples during the first 5 h of release and approximately the same from both sample types for the remaining release period. The co-loaded samples also proved to release the highest amount of cephalothin. The results show that it is possible to load both antibiotics and bisphosphonates simultaneously to a BHA coating on a titanium substrate by a simple soaking procedure. The incorporation of the two different molecules seems to be unaffected or even improved by the presence of the other. The release rate of cephalothin is in agreement with previous studies where it was sufficient for bacteria inhibition in the vicinity of the implant (Brohede et al. 2009a) .
The findings in this study show that it is possible to simultaneously incorporate antibiotics and bisphosphonates to implant coatings comprised of BHA by a simple soaking procedure. To improve the loading procedure, it is suggested to decrease the soaking time as this has been shown to be beneficial for incorporation of bisphosphonates (McLeod et al. 2006 ) and successful incorporation of antibiotics can be achieved already after 15 min (Brohede et al. 2009a) . The proposed strategy with the dual biological effect is believed to decrease the number of postsurgical infections. With the proposed concept, the antibiotic will act during the first few days following The results are displayed as the average concentration in two samples Fig. 1 The left panel displays release profiles of Cephalothin from the co-loaded samples (upper curve) and the samples loaded with Cephalothin alone (lower curve). The solid lines are incorporated as guides for the eye. The right panel shows the Cl 2p peak for the different surfaces. The curves are based on the average values of two measurements on different samples. The difference in intensity corresponds to a difference in occurrence of Cl in the samples while the difference in binding energy corresponds to a difference in atomic environment of the Cl surgery to inhibit bacteria adhesion on the implant surface whereas the bisphosphonate is expected to induce more dense bone formation, thus reducing the risk for immune depression at the interface between bone and implant associated with implant migration.
Conclusions
A successful incorporation of both the antibiotic cephalothin and the bisphosphonate clodronate to a BHA implant coating was achieved via a simple soaking procedure. No negative effects on the incorporation of each substance by the presence of the other was observed and a controlled release of cephalothin was obtained for 43 h, which is believed to prevent immediate adsorption of bacteria on the surface during the crucial first days following surgery. The study proves that the concept of coloaded hydroxyapatite is a potential strategy to reduce the number of post-surgical infections related with biofilm formation and implant migration.
